The FDA has lost no time in approving Vertex Pharma and CRISPR Therapeutics ... when it was cleared by the FDA for sickle cell disease (SCD). The UK was the first country to give the go-ahead ...

Morgan Stanley analyst Chris Quintero maintained a Buy rating on Vertex (VERX – Research Report) today and set a price target of $57.00. The ...

Investing.com -- Stifel downgraded Vertex (NASDAQ:VRTX), Inc to “Hold” from “Buy” and lowered its price target to $31 from $35, over the company’s investment strategy and valuation.

In a report released today, Patrick Walravens from JMP Securities maintained a Buy rating on Vertex (VERX – Research Report), with a price ...

BMO Capital analyst Daniel Jester lowered the firm’s price target on Vertex (VERX) to $41 from $56 and keeps a Market Perform rating on the shares. The firm had previously indicated that shares ...

Breitling finally placed its new, impressively complex in-house movement in a regular production reference. And it is ...

The watch industry never stops ticking. Keep time with the most exciting new releases from G-Shock, Timex, Citizen and more.

Vertex has appointed a new commercial head for ex-US activites, as the company aims to resolve its two-year row with UK health officials over the price of its cystic fibrosis drugs.

How much of life do we make, and how much of it is fate? Well, according to your birth chart in astrology, there's a ...

The changes are expected to begin rolling out on the app over the next few months. The post YouTube wants to make its TV app ...

Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis (CF). It markets TRIKAFTA/KAFTRIO for people with CF ...

Curious about when new episodes will drop and how to watch in the UK? Keep reading for all the details. The show officially returned to Paramount Plus on Sunday 23rd February. New episodes are set ...